APA (7th ed.) Citation

EJ, S., PS, T., M, W., N, S., K, M., S, V., . . . DA, L. (2026). A potent inhibitor of PAI-1, MDI-2517, mitigates disease severity in a preclinical systemic sclerosis model. JCI insight, 11(7), . https://doi.org/10.1172/jci.insight.195005

Chicago Style (17th ed.) Citation

EJ, Su, et al. "A Potent Inhibitor of PAI-1, MDI-2517, Mitigates Disease Severity in a Preclinical Systemic Sclerosis Model." JCI Insight 11, no. 7 (2026). https://doi.org/10.1172/jci.insight.195005.

MLA (9th ed.) Citation

EJ, Su, et al. "A Potent Inhibitor of PAI-1, MDI-2517, Mitigates Disease Severity in a Preclinical Systemic Sclerosis Model." JCI Insight, vol. 11, no. 7, 2026, https://doi.org/10.1172/jci.insight.195005.